Annual Total Liabilities
$4.05 B
+$345.94 M+9.34%
31 December 2023
Summary:
Alnylam Pharmaceuticals annual total liabilities is currently $4.05 billion, with the most recent change of +$345.94 million (+9.34%) on 31 December 2023. During the last 3 years, it has risen by +$1.66 billion (+69.42%). ALNY annual total liabilities is now at all-time high.ALNY Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$4.17 B
+$159.98 M+3.99%
30 September 2024
Summary:
Alnylam Pharmaceuticals quarterly total liabilities is currently $4.17 billion, with the most recent change of +$159.98 million (+3.99%) on 30 September 2024. Over the past year, it has increased by +$167.75 million (+4.19%). ALNY quarterly total liabilities is now at all-time high.ALNY Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALNY Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.3% | +4.2% |
| 3 y3 years | +69.4% | +53.6% |
| 5 y5 years | +1384.6% | +346.5% |
ALNY Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +69.4% | at high | +53.6% |
| 5 y | 5 years | at high | +1384.6% | at high | +348.7% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Alnylam Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.17 B(+4.0%) |
| June 2024 | - | $4.01 B(-0.8%) |
| Mar 2024 | - | $4.04 B(-0.2%) |
| Dec 2023 | $4.05 B(+9.3%) | $4.05 B(+1.1%) |
| Sept 2023 | - | $4.00 B(+5.1%) |
| June 2023 | - | $3.81 B(+4.4%) |
| Mar 2023 | - | $3.65 B(-1.4%) |
| Dec 2022 | $3.70 B(+21.3%) | $3.70 B(+2.8%) |
| Sept 2022 | - | $3.60 B(+14.2%) |
| June 2022 | - | $3.15 B(+4.0%) |
| Mar 2022 | - | $3.03 B(-0.7%) |
| Dec 2021 | $3.06 B(+27.8%) | $3.06 B(+12.5%) |
| Sept 2021 | - | $2.72 B(+2.3%) |
| June 2021 | - | $2.66 B(+14.0%) |
| Mar 2021 | - | $2.33 B(-2.6%) |
| Dec 2020 | $2.39 B(+150.0%) | $2.39 B(+14.3%) |
| Sept 2020 | - | $2.09 B(+6.0%) |
| June 2020 | - | $1.97 B(+112.4%) |
| Mar 2020 | - | $929.89 M(-2.8%) |
| Dec 2019 | $956.44 M(+250.6%) | $956.44 M(+2.3%) |
| Sept 2019 | - | $934.53 M(-2.6%) |
| June 2019 | - | $959.22 M(+105.4%) |
| Mar 2019 | - | $467.01 M(+71.2%) |
| Dec 2018 | $272.84 M(+19.5%) | $272.84 M(+38.1%) |
| Sept 2018 | - | $197.53 M(+17.2%) |
| June 2018 | - | $168.59 M(+0.2%) |
| Mar 2018 | - | $168.33 M(-26.3%) |
| Dec 2017 | $228.30 M(-33.4%) | $228.30 M(-23.8%) |
| Sept 2017 | - | $299.45 M(-3.8%) |
| June 2017 | - | $311.32 M(+2.7%) |
| Mar 2017 | - | $303.02 M(-11.5%) |
| Dec 2016 | $342.59 M(+181.3%) | $342.59 M(+15.0%) |
| Sept 2016 | - | $297.94 M(+5.0%) |
| June 2016 | - | $283.68 M(+121.8%) |
| Mar 2016 | - | $127.90 M(+5.0%) |
| Dec 2015 | $121.80 M(-15.0%) | $121.80 M(+6.3%) |
| Sept 2015 | - | $114.54 M(-6.2%) |
| June 2015 | - | $122.17 M(-7.6%) |
| Mar 2015 | - | $132.28 M(-7.7%) |
| Dec 2014 | $143.33 M | $143.33 M(+75.0%) |
| Sept 2014 | - | $81.88 M(-9.4%) |
| June 2014 | - | $90.39 M(-27.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $125.32 M(-16.6%) |
| Dec 2013 | $150.18 M(-2.1%) | $150.18 M(+0.2%) |
| Sept 2013 | - | $149.92 M(-2.9%) |
| June 2013 | - | $154.38 M(-3.5%) |
| Mar 2013 | - | $160.02 M(+4.3%) |
| Dec 2012 | $153.47 M(-6.4%) | $153.47 M(+5.7%) |
| Sept 2012 | - | $145.19 M(+11.5%) |
| June 2012 | - | $130.19 M(-8.9%) |
| Mar 2012 | - | $142.92 M(-12.8%) |
| Dec 2011 | $163.92 M(-30.3%) | $163.92 M(-10.1%) |
| Sept 2011 | - | $182.35 M(-10.7%) |
| June 2011 | - | $204.28 M(-8.6%) |
| Mar 2011 | - | $223.49 M(-4.9%) |
| Dec 2010 | $235.03 M(-22.5%) | $235.03 M(-6.7%) |
| Sept 2010 | - | $251.96 M(-8.3%) |
| June 2010 | - | $274.70 M(-5.8%) |
| Mar 2010 | - | $291.58 M(-3.9%) |
| Dec 2009 | $303.42 M(-13.9%) | $303.42 M(-3.3%) |
| Sept 2009 | - | $313.65 M(-6.1%) |
| June 2009 | - | $334.17 M(-6.1%) |
| Mar 2009 | - | $355.79 M(+0.9%) |
| Dec 2008 | $352.55 M(+19.7%) | $352.55 M(-6.1%) |
| Sept 2008 | - | $375.62 M(-1.4%) |
| June 2008 | - | $380.88 M(+34.4%) |
| Mar 2008 | - | $283.44 M(-3.8%) |
| Dec 2007 | $294.62 M(+658.7%) | $294.62 M(-5.6%) |
| Sept 2007 | - | $312.16 M(+672.9%) |
| June 2007 | - | $40.39 M(+8.2%) |
| Mar 2007 | - | $37.31 M(-3.9%) |
| Dec 2006 | $38.83 M(+6.2%) | $38.83 M(-2.3%) |
| Sept 2006 | - | $39.75 M(+7.3%) |
| June 2006 | - | $37.04 M(+3.5%) |
| Mar 2006 | - | $35.77 M(-2.2%) |
| Dec 2005 | $36.57 M(+83.2%) | $36.57 M(+81.2%) |
| Sept 2005 | - | $20.18 M(-6.0%) |
| June 2005 | - | $21.47 M(+11.6%) |
| Mar 2005 | - | $19.24 M(-3.6%) |
| Dec 2004 | $19.96 M(-67.7%) | $19.96 M(+13.7%) |
| Sept 2004 | - | $17.56 M(-1.3%) |
| June 2004 | - | $17.80 M(-77.3%) |
| Mar 2004 | - | $78.42 M(+26.7%) |
| Dec 2003 | $61.89 M(+198.2%) | $61.89 M |
| Dec 2002 | $20.76 M | - |
FAQ
- What is Alnylam Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual total liabilities year-on-year change?
- What is Alnylam Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly total liabilities year-on-year change?
What is Alnylam Pharmaceuticals annual total liabilities?
The current annual total liabilities of ALNY is $4.05 B
What is the all time high annual total liabilities for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual total liabilities is $4.05 B
What is Alnylam Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, ALNY annual total liabilities has changed by +$345.94 M (+9.34%)
What is Alnylam Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of ALNY is $4.17 B
What is the all time high quarterly total liabilities for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly total liabilities is $4.17 B
What is Alnylam Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, ALNY quarterly total liabilities has changed by +$167.75 M (+4.19%)